Different effects of nabilone and cannabidiol on binocular depth inversion in Man
- PMID: 10837858
- DOI: 10.1016/s0091-3057(00)00201-x
Different effects of nabilone and cannabidiol on binocular depth inversion in Man
Abstract
The physiological and pathophysiological roles of the central nervous endogenous cannabinoid system are not completely understood, but still represent a challenge in basic neurobiological, cognitive, and psychiatric research. The system has been implicated in the pathogenesis of schizophrenia. Binocular depth inversion, an illusion of visual perception, provides a model of impaired perception during psychotic states. Using this model the effects of nabilone, a psychoactive synthetic 9-trans-ketocannabinoid, and of cannabidiol, the main natural component of herbal cannabis, and a combined application of both substances on binocular depth inversion and behavioural states were investigated in nine healthy male volunteers. The time course of the effects of both substances on binocular depth inversion was analysed after oral administration using three different groups of natural stimuli. A significant impairment of binocular depth perception was found when nabilone was administered, but combined application with cannabidiol revealed somewhat reduced effects on binocular depth inversion. The influence of psychoactive cannabinoids on this perceptual model and the role of the endogenous cannabinoid system in visual information processing are discussed.
Similar articles
-
Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man.Psychopharmacology (Berl). 1999 Mar;142(3):230-5. doi: 10.1007/s002130050884. Psychopharmacology (Berl). 1999. PMID: 10208314
-
Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment.Pharmacol Biochem Behav. 1991 Nov;40(3):689-90. doi: 10.1016/0091-3057(91)90383-d. Pharmacol Biochem Behav. 1991. PMID: 1666928
-
Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man.J Psychopharmacol. 2003 Mar;17(1):51-6. doi: 10.1177/0269881103017001698. J Psychopharmacol. 2003. PMID: 12680739 Clinical Trial.
-
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.Braz J Med Biol Res. 2006 Apr;39(4):421-9. doi: 10.1590/s0100-879x2006000400001. Epub 2006 Apr 3. Braz J Med Biol Res. 2006. PMID: 16612464 Review.
-
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.Eur J Pain. 2018 Mar;22(3):471-484. doi: 10.1002/ejp.1148. Epub 2017 Nov 21. Eur J Pain. 2018. PMID: 29160600 Review.
Cited by
-
Does cannabis affect cognitive functioning in patients with schizophrenia?Schizophr Res Cogn. 2023 Dec 20;36:100299. doi: 10.1016/j.scog.2023.100299. eCollection 2024 Jun. Schizophr Res Cogn. 2023. PMID: 38196922 Free PMC article.
-
The Impact of THC and CBD in Schizophrenia: A Systematic Review.Front Psychiatry. 2021 Jul 23;12:694394. doi: 10.3389/fpsyt.2021.694394. eCollection 2021. Front Psychiatry. 2021. PMID: 34366924 Free PMC article.
-
State anxiety influences P300 and P600 event-related potentials over parietal regions in the hollow-mask illusion experiment.Personal Neurosci. 2021 Feb 16;4:e2. doi: 10.1017/pen.2020.16. eCollection 2021. Personal Neurosci. 2021. PMID: 33954275 Free PMC article.
-
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers.Front Psychiatry. 2020 Nov 13;11:576877. doi: 10.3389/fpsyt.2020.576877. eCollection 2020. Front Psychiatry. 2020. PMID: 33304282 Free PMC article.
-
Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research.Sports Med Open. 2020 Jul 6;6(1):27. doi: 10.1186/s40798-020-00251-0. Sports Med Open. 2020. PMID: 32632671 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
